Add to ORKGBackground: Low-molecular-weight heparin has greatly simpli-fied the management of deep venous thrombosis. However, for patients who present with pulmonary embolism, the role of low-molecular-weight heparin is uncertain and unfractionated heparin remains widely used. Purpose: To compare the efficacy and safety of fixed-dose sub-cutaneous low-molecular-weight heparin with that of dose-ad-justed intravenous unfractionated heparin to treat acute pulmonary embolism. Data Sources: The MEDLINE, EMBASE, and Cochrane Library databases were searched up to 1 August 2003. Additional data sources were manual searches of abstract proceedings and per-sonal contact with investigators and pharmaceutical companies. Study Selection: Randomized trials compari...
BACKGROUND: An intravenous course of standard (unfractionated) heparin with the dose adjusted to pro...
BACKGROUND: In patients with acute venous thromboembolism and renal insufficiency, initial therapy w...
BACKGROUND: In patients with acute venous thromboembolism and renal insufficiency, initial therapy...
International audienceBACKGROUND: Low-molecular-weight heparin appears to be at least as effective a...
Unfractionated heparin is the traditional treatment of choice for patients presenting with submassiv...
Background Low-molecular-weight heparin is known to be safe and effective for the initial Treatment ...
PURPOSE: To obtain reliable estimates of the relative efficacy and safety of low-molecular-weight he...
Background: Low molecular weight heparins (LMWHs) have been shown to be effective and safe in preven...
Background Low molecular weight heparins (LMWHs) have been shown to be effective and safe in prevent...
AbstractObjective: To evaluate the methodology and cumulative evidence presented in systematic revie...
International audienceSTUDY OBJECTIVES: Low-molecular-weight heparins have been compared with unfrac...
We compared the efficacy and safety of low molecular weight heparins (LMWH) and unfractionate...
Background Despite its limitations, unfractionated heparin (UFH) is the recommended anticoagulant du...
There were few questions about the advantages of subcutaneous unfractionated heparin (UFH) relative ...
Purpose: The role of low-molecular-weight heparin (LMWH) in managing nonmassive pulmonary embolism (...
BACKGROUND: An intravenous course of standard (unfractionated) heparin with the dose adjusted to pro...
BACKGROUND: In patients with acute venous thromboembolism and renal insufficiency, initial therapy w...
BACKGROUND: In patients with acute venous thromboembolism and renal insufficiency, initial therapy...
International audienceBACKGROUND: Low-molecular-weight heparin appears to be at least as effective a...
Unfractionated heparin is the traditional treatment of choice for patients presenting with submassiv...
Background Low-molecular-weight heparin is known to be safe and effective for the initial Treatment ...
PURPOSE: To obtain reliable estimates of the relative efficacy and safety of low-molecular-weight he...
Background: Low molecular weight heparins (LMWHs) have been shown to be effective and safe in preven...
Background Low molecular weight heparins (LMWHs) have been shown to be effective and safe in prevent...
AbstractObjective: To evaluate the methodology and cumulative evidence presented in systematic revie...
International audienceSTUDY OBJECTIVES: Low-molecular-weight heparins have been compared with unfrac...
We compared the efficacy and safety of low molecular weight heparins (LMWH) and unfractionate...
Background Despite its limitations, unfractionated heparin (UFH) is the recommended anticoagulant du...
There were few questions about the advantages of subcutaneous unfractionated heparin (UFH) relative ...
Purpose: The role of low-molecular-weight heparin (LMWH) in managing nonmassive pulmonary embolism (...
BACKGROUND: An intravenous course of standard (unfractionated) heparin with the dose adjusted to pro...
BACKGROUND: In patients with acute venous thromboembolism and renal insufficiency, initial therapy w...
BACKGROUND: In patients with acute venous thromboembolism and renal insufficiency, initial therapy...